UB-621 is a human IgG1 monoclonal antibody that targets conserved gD protein of Herpes simplex virus (HSV) type I and type II.
Features
Neutralizes both HSV-1 and HSV-2
Long half-life up to 25 days
The leading antibody drug for treatment of HSV infection
High binding affinity to the gD protein : 3.6 x 10-11 M
Potential indication
Recurrent genital herpes
Small molecule antiviral drug resistant HSV infection
Prevention of neonatal HSV infection
Market Opportunity
Global genital herpes treatment market size was about US$ 0.7 B in 2016.
Unmet need
Chronic suppression is currently not available
Drug resistance problem
To:
Mr.Sales DepartmentGREAT COMPUTER CORPORATION
Quantity
-
+
Estimated PurchaseAmount
Mamessage
Email
Tel
Submit
This is a notification message!
To help you see through the fog on Facebook, we generate new features on local
directory Poter for social marketing and put together some tips on how to use Facebook for business.